Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Vincristine sulfate: Reliable Cell Assay Workflows
2026-08-28
Learn how Vincristine sulfate (SKU A1765) supports reproducible viability, proliferation, and cytotoxicity experiments through a defined microtubule-disruption mechanism and practical solubility guidance. This scenario-based guide covers assay design, dose selection, data interpretation, and product evaluation for cancer research.
-
Phage-Layer Interferometry for Phage Diagnostics
2026-08-28
The reference study introduces phage-layer interferometry (PLI) as a quantitative companion diagnostic for selecting therapeutic phages and as a prototype platform for bacterial detection. Its key practical advance is real-time, automatable analysis that remains usable in complex opaque matrices, where conventional optical assays are difficult to interpret.
-
CCT007093: PPM1D Inhibitor Workflow
2026-08-27
CCT007093 is a practical chemical probe for connecting PPM1D inhibition with p38 signaling, viability loss, and inflammatory cell-death phenotypes. This workflow shows how to move from solvent and dose controls to mechanistic rescue experiments in breast cancer and renal tubular models.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-08-27
This reagent provides HRP-mediated detection of rabbit primary IgG in Western blot, ELISA, IHC, and IC workflows. It should be used as a research secondary antibody with assay-specific optimization, not as a diagnostic reagent or as evidence of performance beyond the supplied product dossier.
-
Bradykinin: Practical Assay Handling Guide
2026-08-26
Bradykinin (SKU BA5201) provides a defined peptide perturbation for vascular reactivity, permeability, smooth muscle, pain, and inflammation experiments. This guide covers storage, solution handling, controls, and troubleshooting; the material is for scientific research only and should not be used for diagnosis, treatment, or direct medical application.
-
Catalpol, Glycolysis, and EphA2 in Liver Fibrosis
2026-08-26
The reference study identifies a mechanistic link between catalpol, aerobic glycolysis, and EphA2/FAK/Src signaling in hepatic stellate cells. Using complementary mouse and cell models, it shows that catalpol reduces stellate-cell activation, inflammation, and fibrotic remodeling, while highlighting EphA2 as a potential metabolic control point.
-
Biotin-XX Tyramide Reagent in Spatial Proteomics
2026-08-25
Biotin-XX Tyramide Reagent combines HRP-driven amplification with membrane exclusion for selective cell-surface detection in tissue sections. This guide translates its chemistry into practical IHC, ISH, multiplex imaging, and proximity-proteomics workflows, with starting parameters and troubleshooting advice.
-
Nystatin (Fungicidin): Mechanism & Benchmarks
2026-08-25
Nystatin, also called Fungicidin, is an ergosterol-binding polyene antifungal used in Candida and Aspergillus research. Product-dossier benchmarks include species-dependent Candida inhibition, reduced epithelial adhesion, and protective activity from liposomal Nystatin in neutropenic mice.
-
Neuromedin S (rat): Protocol and QC Guide
2026-08-24
Neuromedin S (rat) provides a defined endogenous peptide agonist for controlled studies of neuromedin U receptor signaling and GPCR/G protein signaling in rat-relevant systems. It supports research workflows involving energy homeostasis regulation and stress response research, but the dossier does not establish potency, therapeutic suitability, diagnostic use, or cross-species performance.
-
GW4064: FXR Signaling in Fibrosis Assays
2026-08-24
GW4064 is a non-steroidal FXR agonist that connects receptor pharmacology with lipid metabolism and toxicant-associated fibrosis research. This article explains how to design more informative FXR assays by integrating pathway, ferroptosis, and collagen readouts.
-
Macrophage EP4 Loss in Atherosclerosis
2026-08-23
A 2025 Cells study identifies macrophage EP4 as a protective regulator of atherosclerosis, linking its deficiency to increased CD36 expression, foam-cell formation, and M1 polarization. The work combines a myeloid EP4 knockout model, oxLDL-stimulated macrophages, transcriptomics, proteomics, Western blotting, and qPCR to connect an in vivo plaque phenotype with a candidate molecular mechanism.
-
Luminescent ATP Detection Assay Kit in NSCLC
2026-08-22
Use a firefly luciferase ATP assay to connect pyruvate carboxylase activity with energy status, ferroptosis susceptibility, and tumor progression in NSCLC models. The workflow combines rapid lysis, broad 1 nM–10 μM linearity, and downstream-compatible sample handling for cellular and tissue studies.
-
Palmitic acid: Protocol Parameters and QC
2026-08-22
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid for lipid metabolism, signaling, and metabolic disorder research. It is intended for solvent-based preparation and prompt use, not aqueous dissolution or long-term storage as a solution.
-
Acetylcholine Chloride in Gut-Brain Assays
2026-08-21
Acetylcholine Chloride provides a defined cholinergic comparator for testing how microbial signals influence vagal, intestinal, and neuronal function. This practical guide connects the Bacteroides fragilis antiseizure study with reproducible formulation, concentration-response, ex vivo, and troubleshooting workflows.
-
GANT61: A GLI Inhibitor for Assay Design
2026-08-20
GANT61 is a GLI inhibitor for dissecting distal Hedgehog signaling in cancer models. This article presents an assay-centered framework for connecting GLI2 activity with tumor-cell phenotypes, WNT and prostaglandin signals, and immune suppression without overinterpreting pathway-level results.